RGD-containing ligands for targeting liposomal nanoparticles
The use of a targeting ligand to enhance the delivery of liposomal nanoparticles (LNs) to specific cells in diseased tissue is an attractive strategy that has progressed very slowly since the idea originated over 25 years ago. The slow progress can be attributed, in part, to the difficulties involve...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
University of British Columbia
2011
|
| Online Access: | http://hdl.handle.net/2429/31279 |